Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Schering takes Resovist to Japan:

This article was originally published in Clinica

Executive Summary

Schering has received Japanese market approval for its liver-specific MRI contrast media, Resovist. The product will be marketed by the firm's Japanese subsidiary, Nihon Schering KK. Resovist, which was approved in Europe in 2001, will be available in around ten countries by the end of the year, said Schering. It is used for the detection and characterisation of especially small focal liver lesions, enabling doctors to make a reliable diagnosis at a very early stage, the company added.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts